A 52-year-old man with NYHA Class IV heart failure is referred for cardiopulmonary exercise testing (CPET) to guide transplantation decisions. His peak VO2 is measured at 13.2 mL/kg/min (not on beta-blocker therapy). The structure marked **B** in the diagram represents this critical threshold value. Based on the ISHLT 2016 listing criteria, what is the primary clinical significance of this finding?
A. Peak VO2 <14 mL/kg/min indicates 1-year survival of 50–60% without transplant and supports listing for cardiac transplantation
B. Peak VO2 <14 mL/kg/min is a relative contraindication to transplantation due to poor functional reserve
C. Peak VO2 <14 mL/kg/min indicates excellent prognosis with medical therapy alone and transplantation should be deferred
D. Peak VO2 <14 mL/kg/min reflects primarily pulmonary dysfunction and requires pulmonary rehabilitation before transplant consideration
Explanation
Why Peak VO2 <14 mL/kg/min indicates 1-year survival of 50–60% without transplant and supports listing for cardiac transplantation is right
The structure marked B in the diagram represents the critical threshold of peak VO2 <14 mL/kg/min, which is the most important CPET parameter for prognostication in advanced heart failure. According to the ISHLT 2016 listing criteria (updated from the Mancini criteria, 1991), a peak VO2 <14 mL/kg/min (or <12 mL/kg/min if on beta-blocker therapy) identifies patients with a 1-year survival of only 50–60% without transplantation. This poor prognosis indicates that the survival benefit of heart transplantation outweighs the operative and immunosuppressive risks, thereby supporting listing for cardiac transplantation. Peak VO2 reflects the integrated capacity of the heart to deliver oxygen (via cardiac output and arterial oxygen content) and the skeletal muscles to extract it (Fick equation), making it a robust measure of functional capacity and prognostic risk in HF.
Why each distractor is wrong
Peak VO2 <14 mL/kg/min indicates excellent prognosis with medical therapy alone and transplantation should be deferred: This directly contradicts the ISHLT 2016 criteria. A peak VO2 <14 mL/kg/min is associated with poor prognosis (50–60% 1-year survival without transplant), not excellent prognosis. Deferring transplantation in this group would result in preventable mortality.
Peak VO2 <14 mL/kg/min is a relative contraindication to transplantation due to poor functional reserve: This is backwards. A low peak VO2 is an indication for transplantation, not a contraindication. Contraindications include irreversible pulmonary hypertension, end-organ failure, and active malignancy—not low functional capacity.
Peak VO2 <14 mL/kg/min reflects primarily pulmonary dysfunction and requires pulmonary rehabilitation before transplant consideration: Peak VO2 in heart failure reflects cardiac dysfunction (impaired oxygen delivery by the heart) and skeletal muscle dysfunction, not primarily pulmonary disease. While spirometry may show restrictive patterns in HF, it is not useful for prognostication in HF; CPET is the gold standard. Pulmonary rehabilitation would not improve the underlying cardiac pathology.
High-YieldNEET PG
Peak VO2 <14 mL/kg/min (or <12 on beta-blocker) = 50–60% 1-year survival without transplant = list for transplantation; peak VO2 >18 mL/kg/min = >80% 1-year survival = do not list yet.
ISHLT Listing Criteria for Heart Transplantation 2016; Mancini et al., 1991
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
